Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.360
-0.040 (-9.95%)
At close: Apr 28, 2026, 4:00 PM EDT
0.362
+0.002 (0.53%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Mangoceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.46 | 0.62 | 0.73 | 0.01 | - |
| Revenue Growth (YoY) | -25.96% | -15.81% | 8083.16% | - | - |
| Cost of Revenue | 0.21 | 0.24 | 0.3 | 0 | - |
| Gross Profit | 0.25 | 0.38 | 0.43 | 0 | - |
| Selling, General & Admin | 5.93 | 5.54 | 6.39 | 2 | 0.07 |
| Amortization of Goodwill & Intangibles | 1.12 | 0.72 | - | - | - |
| Operating Expenses | 17.84 | 8.62 | 8.55 | 2 | 0.07 |
| Operating Income | -17.59 | -8.24 | -8.12 | -1.99 | -0.07 |
| Interest Expense | -0.1 | -0.01 | - | -0.01 | -0 |
| Interest & Investment Income | - | - | 0.01 | - | - |
| Other Non Operating Income (Expenses) | -1.56 | -0.45 | -1.1 | - | - |
| EBT Excluding Unusual Items | -19.26 | -8.71 | -9.21 | -2 | -0.07 |
| Asset Writedown | -1.24 | - | - | - | - |
| Legal Settlements | -0.13 | - | - | - | - |
| Other Unusual Items | -0.02 | - | - | - | - |
| Pretax Income | -20.64 | -8.71 | -9.21 | -2 | -0.07 |
| Earnings From Continuing Operations | -20.64 | -8.71 | -9.21 | -2 | -0.07 |
| Minority Interest in Earnings | 0 | 0 | - | - | - |
| Net Income | -20.64 | -8.71 | -9.21 | -2 | -0.07 |
| Preferred Dividends & Other Adjustments | 1.18 | 0.8 | - | - | - |
| Net Income to Common | -21.82 | -9.51 | -9.21 | -2 | -0.07 |
| Shares Outstanding (Basic) | 10 | 2 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 10 | 2 | 1 | 1 | 1 |
| Shares Change (YoY) | 408.93% | 84.23% | 49.22% | 34.98% | - |
| EPS (Basic) | -2.17 | -4.80 | -8.58 | -2.78 | - |
| EPS (Diluted) | -2.17 | -4.80 | -8.58 | -2.78 | - |
| Free Cash Flow | -5.85 | -4.86 | -7 | -1.39 | -0.07 |
| Free Cash Flow Per Share | -0.58 | -2.46 | -6.52 | -1.93 | -0.13 |
| Gross Margin | 54.91% | 61.70% | 58.99% | 54.26% | - |
| Operating Margin | -3858.11% | -1337.90% | -1109.84% | -22279.70% | - |
| Profit Margin | -4784.65% | -1543.87% | -1259.40% | -22352.11% | - |
| Free Cash Flow Margin | -1282.89% | -789.74% | -957.07% | -15545.59% | - |
| EBITDA | -15.87 | -7.51 | -8.09 | -1.99 | - |
| D&A For EBITDA | 1.72 | 0.73 | 0.02 | 0 | - |
| EBIT | -17.59 | -8.24 | -8.12 | -1.99 | -0.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.